Integra LifeSciences (IART) Competitors $12.31 -0.83 (-6.32%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$12.30 -0.01 (-0.04%) As of 08/1/2025 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IART vs. ATEC, ATRC, SRDX, OFIX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Alphatec (ATEC), AtriCure (ATRC), Surmodics (SRDX), Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Integra LifeSciences vs. Its Competitors Alphatec AtriCure Surmodics Orthofix Medical AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Is ATEC or IART more profitable? Alphatec has a net margin of -24.33% compared to Integra LifeSciences' net margin of -30.87%. Integra LifeSciences' return on equity of 11.18% beat Alphatec's return on equity.Company Net Margins Return on Equity Return on Assets Alphatec-24.33% -1,657.19% -21.59% Integra LifeSciences -30.87%11.18%4.22% Which has stronger earnings & valuation, ATEC or IART? Integra LifeSciences has higher revenue and earnings than Alphatec. Integra LifeSciences is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlphatec$642.27M3.13-$162.12M-$1.13-12.19Integra LifeSciences$1.61B0.59-$6.94M-$0.38-32.39 Does the media favor ATEC or IART? In the previous week, Integra LifeSciences had 4 more articles in the media than Alphatec. MarketBeat recorded 17 mentions for Integra LifeSciences and 13 mentions for Alphatec. Alphatec's average media sentiment score of 0.81 beat Integra LifeSciences' score of 0.57 indicating that Alphatec is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 2 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 4 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of ATEC or IART? 66.3% of Alphatec shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 20.9% of Alphatec shares are held by company insiders. Comparatively, 3.5% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk and volatility, ATEC or IART? Alphatec has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Do analysts rate ATEC or IART? Alphatec presently has a consensus target price of $18.33, suggesting a potential upside of 33.14%. Integra LifeSciences has a consensus target price of $18.63, suggesting a potential upside of 51.30%. Given Integra LifeSciences' higher possible upside, analysts clearly believe Integra LifeSciences is more favorable than Alphatec.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alphatec 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Integra LifeSciences 4 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.78 SummaryIntegra LifeSciences beats Alphatec on 10 of the 16 factors compared between the two stocks. Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IART vs. The Competition Export to ExcelMetricIntegra LifeSciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.02B$6.77B$5.47B$9.53BDividend YieldN/A1.32%4.74%4.08%P/E Ratio-1.8920.9428.6723.80Price / Sales0.5959.01422.3188.12Price / Cash2.9520.5035.4557.96Price / Book0.614.468.275.55Net Income-$6.94M$174.54M$3.24B$259.03M7 Day Performance-6.10%-5.27%-3.63%-4.56%1 Month Performance-8.95%-3.94%4.40%4.49%1 Year Performance-48.79%8.26%25.97%18.05% Integra LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IARTIntegra LifeSciences4.2444 of 5 stars$12.31-6.3%$18.63+51.3%-50.0%$1.02B$1.61B-1.894,396Trending NewsEarnings ReportGap DownHigh Trading VolumeATECAlphatec4.3219 of 5 stars$10.31-1.7%$18.13+75.8%+107.4%$1.51B$611.56M-8.97700Trending NewsAnalyst ForecastGap UpATRCAtriCure3.3155 of 5 stars$29.24-0.1%$50.67+73.3%+63.5%$1.45B$480.08M-36.101,300News CoverageEarnings ReportAnalyst ForecastSRDXSurmodics3.8284 of 5 stars$31.17+3.2%$43.00+38.0%-12.8%$445.73M$126.08M-22.42450Positive NewsOFIXOrthofix Medical2.2356 of 5 stars$10.67+0.4%$21.50+101.5%-31.7%$418.05M$799.49M-2.891,616Upcoming EarningsANGOAngioDynamics3.9409 of 5 stars$8.99+3.5%$19.00+111.3%+9.9%$365.08M$292.50M-10.83760ARAYAccuray3.2148 of 5 stars$1.34+0.4%N/A-24.3%$138.03M$446.55M0.001,040RMTIRockwell Medical4.147 of 5 stars$1.12+1.8%$4.00+257.1%-47.8%$38.28M$97.73M0.00300RSLSReShape Lifesciences0.6444 of 5 stars$2.91-8.5%N/A-99.1%$6.94M$7.18M-0.0250ABTAbbott Laboratories4.9814 of 5 stars$124.27+0.5%$144.47+16.3%+15.6%$216.21B$41.95B15.57114,000Positive NewsISRGIntuitive Surgical4.7298 of 5 stars$516.12-0.5%$592.86+14.9%+7.1%$184.99B$8.35B75.6815,638Positive NewsInsider Trade Related Companies and Tools Related Companies ATEC Alternatives ATRC Alternatives SRDX Alternatives OFIX Alternatives ANGO Alternatives ARAY Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives ISRG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IART) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IART Stock Alerts